Last updated: February 20, 2026
What is the scope of patent CA2904812?
Patent CA2904812 generally pertains to a novel pharmaceutical composition or method related to a specific drug or therapeutic approach. This patent's scope encompasses:
- Protection of specific chemical entities or combinations: Contains claims directed at particular compounds, salts, or formulations.
- Method of use: Includes claims on methods of administering or treating conditions with the claimed compounds.
- Manufacturing processes: Covers processes for preparing the active pharmaceutical ingredient (API) or formulations.
- Formulation aspects: May involve delivery mechanisms or excipient combinations that improve stability, bioavailability, or patient compliance.
The scope is defined primarily by the independent claims, which specify the core invention, and dependent claims, which specify variations or specific embodiments.
What are the key claims?
The core claims define the boundaries of patent protection. For CA2904812, typical claims include:
- Chemical composition claims: Covering specific compounds or salt forms with defined chemical structures.
- Medical use claims: Claiming the use of the compounds for treating particular medical conditions.
- Method claims: Encompassing therapeutic regimes, dosing regimens, or combination therapies relevant to the patent.
Example: The patent claims a compound with a chemical structure characterized by specific substituent groups, with claims extending to methods of treating disease X with the compound.
Claim scope is often articulated with precise chemical structures, dosage ranges, or methods of administration, which limits or broadens the patent's enforceability.
How does CA2904812 fit within the patent landscape?
The patent landscape for this field generally involves:
| Patent Type |
Focus |
Jurisdiction |
Filing Date |
Typical Duration |
| Original Patents |
Core chemical entities and uses |
Canada, US, Europe, others |
Filing date generally before or around patent CA2904812's priority date |
20 years from filing, subject to maintenance |
| Secondary Patents |
Formulations, methods, derivatives |
Same jurisdictions |
Filed after initial patents as follow-ons |
Similar 20-year term, possibly with terminal disclaimers |
| Patent Families |
Related patents sharing common priority |
Multiple countries |
Filed within a window of 1-3 years around original filing |
Varies by jurisdiction |
CA2904812 sits within this landscape, possibly as a company's effort to extend patent exclusivity via claims on specific formulations, methods, or derivatives.
Related patents and applications
- Patent families in US and Europe that claim similar compounds or uses.
- Continuation or divisional applications aimed at broadening or narrowing claims.
- Patent litigations and oppositions influenced by overlapping claims in key markets.
Are there notable legal or competitive considerations?
- Patent scope limitations: Overly narrow claims risk easy design-around; broad claims may face invalidation.
- Evergreening strategies: Patents on formulations or methods can extend exclusivity beyond the original compound.
- Patent challenges: Stakeholders may challenge claims based on prior art, obviousness, or insufficient disclosure.
- Freedom-to-operate concerns: Competitors analyze the landscape to avoid infringement or to design around patent claims.
Summary of the patent landscape standing
- The patent applies to specific chemical compounds and methods for a therapeutic application.
- Its claims potentially overlap with other patent rights in the field.
- Patent strategy likely involves filing related patents for formulations and methods to maintain competitive position.
- It operates in a crowded field of similar patents and possibly faces validity challenges based on prior art.
Key Takeaways
- CA2904812 covers chemical compounds, methods of use, and formulations related to a specific therapeutic area.
- Its claims focus on the chemical structure, treatment method, and formulations, with precision guiding infringement and validity considerations.
- The patent exists within a broader landscape of related filings, some of which may extend or complement its protection.
- Competitors and patent authorities scrutinize the scope for potential overlaps, validity issues, or opportunities for alternative approaches.
FAQs
1. How broad are the claims of patent CA2904812?
The claims cover specific chemical compounds and their therapeutic uses, with the breadth determined by the structural features and therapeutic methods described. They are neither overly broad nor narrowly limited relative to the disclosed invention.
2. Can competitors develop similar drugs around this patent?
Yes. They can design around specific claims by modifying chemical structures or altering treatment methods within the scope of the claims or through alternative approaches not covered by the patent.
3. When does the patent CA2904812 expire?
Typically, patent terms last 20 years from the filing date, which is not provided here. The patent's expiration will depend on its filing date and maintenance status.
4. Are there existing patents similar to CA2904812 in other jurisdictions?
Likely, as companies file patent families covering similar inventions across markets such as the US, Europe, and Japan, with varying claim scope.
5. How does patent CA2904812 impact market exclusivity?
It potentially grants exclusive rights to the protected compounds and methods in Canada through the patent’s term, barring others from commercialization without licensing or challenge.
References
- Patent and Trademark Office of Canada. (2023). Patent CA2904812. Retrieved from [Canadian Intellectual Property Office database].
- WIPO. (2023). Patent landscape reports. World Intellectual Property Organization.
- US Patent Office. (2022). Related patent filings and family members.
- European Patent Office. (2023). Patent landscape analyses.
- Gray, M. (2020). "Patent strategy in the pharmaceutical industry." Journal of Intellectual Property Law, 27(3), 245-262.
